Home > News > Webcast of Conference Call to Discuss NUCRYST Pharmaceuticals' results
September 7th, 2004
Webcast of Conference Call to Discuss NUCRYST Pharmaceuticals' results
Abstract:
The Westaim Corporation will hold a webcast at 9:00 a.m. EDT on Wednesday September 8, 2004 regarding
NUCRYST Pharmaceuticals' results of its first Phase 2a human clinical trial. The investigational drug (NPI 32101) is being studied for atopic dermatitis, a form of eczema, and represents a biological application of nanotechnology.
Source:
PRNewswire
Related News Press |
Nanomedicine
High-tech 'paint' could spare patients repeated surgeries March 8th, 2024
Researchers develop artificial building blocks of life March 8th, 2024
Announcements
What heat can tell us about battery chemistry: using the Peltier effect to study lithium-ion cells March 8th, 2024
Nanoscale CL thermometry with lanthanide-doped heavy-metal oxide in TEM March 8th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||